Evidence map›Paper›PMID 29801523›Full record

ReviewTrends in neurosciences2018

Peptide-Mediated Neurotransmission Takes Center Stage.

Aneysis D Gonzalez-Suarez, Michael N Nitabach

Abstract readReview
In one paragraph

Review in Trends in neurosciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Aneysis D Gonzalez-SuarezInterdepartmental Neuroscience Program, Yale University, New Haven, CT 06520, USA.
Michael N NitabachDepartment of Cellular and Molecular Physiology, Yale University, New Haven, CT 06520, USA; Department of Genetics, Yale University, New Haven, CT 06520, USA; Kavli Institute for Neuroscience, Yale University, New Haven, CT 06520, USA. Electronic address: michael.nitabach@yale.edu.
Yale University · US

Funding

Synaptic Microcircuits Underlying Associative LearningR01NS091070 · NINDS · YALE UNIVERSITY · PI NITABACH, MICHAEL · 2014 to 2024
$4.0M
Peptide Modulation of Physiology and BehaviorR01GM098931 · NIGMS · YALE UNIVERSITY · PI NITABACH, MICHAEL · 2011 to 2019
$3.0M
Training Program in Molecular MedicineT32GM100884 · NIGMS · YALE UNIVERSITY · PI LISTER, GEORGE, NITABACH, MICHAEL · 2013 to 2022
$1.8M
NIGMS NIH HHS R01 GM098931NIGMS NIH HHS T32 GM100884NINDS NIH HHS R01 NS091070
6 · The paper itself

Abstract

Today, we understand peptide transmitters to be signaling molecules that modulate neural activity. However, in 1982 little was known about neuropeptides and their role in neural communication. The influential 1982 paper by Jan and Jan reported definitive evidence that a presynaptically released neuropeptide evokes postsynaptic responses in an identified cholinergic synapse, thereby fueling a new era in neuroscience.

Indexed as

AnimalsHumansNeuropeptidesPresynaptic TerminalsSynaptic TransmissionNeuropeptidesLHRHneuropeptidesneurotransmissionpeptide transmitterssignaling molecules

Identifiers

PMID29801523
PMCPMC5975383
OpenAlexW2803791717

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.